We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGen.electric Regulatory News (GEC)

Share Price Information for Gen.electric (GEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 105.00
High: 0.00
Low: 0.00
Prev. Close: 105.00
GEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Aug 2020 07:00

RNS Number : 7643W
General Electric Company
20 August 2020
 

 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 4 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response.................0.5

o Check this box if no longersubject to Section 16. Form 4or Form 5 obligations may continue.See Instruction 1(b).

 

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person*

 

CULP H LAWRENCE

 

JR

2. Issuer Name and Ticker or Trading Symbol

GENERAL ELECTRIC [GE]

5. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

 

  X Director 10% Owner

(Last) (First)

 

GENERAL ELECTRIC COMPANY 5 NECCO STREET

(Middle)

3. Date of Earliest Transaction (Month/Day/Year) 08/18/2020

  X

Officer (give Other (specify title below) below)

   Chairman and CEO

(Street)

BOSTON MA

02210

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

  X Form filed by One Reporting Person

Form filed by More than One Reporting Person

(City) (State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (Instr. 3)

2. Transaction Date (Month/Day/ Year)

2A.

Deemed Execution Date, if any (Month/

Day/ Year)

3. Transaction Code (Instr. 8)

4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

5. Amount of Securities Beneficially Owned Following Reported Transaction(s)

(Instr. 3 and 4)

6. Ownership Form:

Direct

(D) or Indirect (I) (Instr. 4)

7. Nature of Indirect Beneficial Ownership (Instr. 4)

 

 

Code

 

 

V

 

 

Amount

 

(A)

or (D)

 

 

Price

Common Stock

08/18/2020

 

A

 

13,943,028

(1)(2)

A

$0.00

13,943,028

D

 

Common Stock

 

 

 

 

 

 

 

1,169,684

I

By holding company

Common Stock

 

 

 

 

 

 

 

12,592

I

By family trusts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

*If the form is filed by more than one reporting person, see Instruction 4(b)(v).

 

Page 1 of 2

 

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

 

1. Title of Derivative Security (Instr. 3)

2 .Conversion or Exercise Price of Derivative Security

3.

Transaction Date (Month/Day/ Year)

3A.

Deemed Execution Date, if any (Month/ Day/ Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10.

Ownership Form: Direct (D) or Indirect

(I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

 

 

 

Date Exer-

cisable

 

 

Expira- tion Date

 

 

Title

 

 

Amount or Number of

Shares

 

 

 

Code

 

 

V

 

 

(A)

 

 

(D)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Explanation of Responses:

1. Represents performance shares that will vest, subject to continued employment conditions and accelerated vesting in certain circumstances, based upon the highest average closing price of the company's stock for any 30 consecutive trading days during the five-year performance period from August 18, 2020 to August 17, 2025: one-third of the performance shares will be eligible to vest upon achieving a stock price equal to 150% (the "threshold target") of the average of the closing prices of the company's stock over the period of 30 consecutive trading days up to and including the grant date (the "30-day average price"), two-thirds of the performance shares will be eligible to vest upon achieving a stock price equal to 200% of the 30-day average price and all of the performance shares will be eligible to vest upon achieving a stock price equal to 250% (the "maximum target") of the 30-day average price.

2. No performance shares will vest below the threshold target, and the amount of performance shares that vest between the threshold target and maximum target will be determined by linear interpolation.

 

Remarks:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.

 

/s/ Brandon Smith on behalf of H. Lawrence Culp, Jr.

 

8/20/2020

See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

** Signature of Reporting Person

Date

 

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,

see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

 

Page 2 of 2

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAFPEAFDEEAA
Date   Source Headline
23rd Apr 20241:59 pmRNSDoc re. GE Files 8-K
23rd Apr 20241:57 pmRNS1st Quarter Results
15th Apr 20243:27 pmRNSDirector/PDMR Shareholding
11th Apr 20242:39 pmRNSDoc re. GE Files 8-K
9th Apr 20247:00 amRNSDoc re. GE Files 8-K
9th Apr 20247:00 amRNSDoc re. GE Files 8-K/A
5th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 202412:59 pmRNSDoc re. GE Files 8-K
2nd Apr 20247:00 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSDoc re. GE Files Form ARS
15th Mar 20247:00 amRNSDoc re. GE Files Form DEFA 14A
15th Mar 20247:00 amRNSDoc re. GE Files Def 14A
7th Mar 20243:15 pmRNSDoc re. GE Files 8-K
6th Mar 20247:00 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSDoc re. GE Files 8-K
1st Mar 20247:00 amRNSDoc re. GE Files 8-K
1st Mar 20247:00 amRNSDoc re. GE Files 8-K
28th Feb 20247:00 amRNSDirector/PDMR Shareholding
28th Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
2nd Feb 20242:01 pmRNSDoc re. GE Files Form S-3
2nd Feb 202412:55 pmRNSAnnual Financial Report
23rd Jan 20241:55 pmRNSDoc re. GE Files 8-K
17th Jan 20247:00 amRNSDoc re. GE Files 8-K/A
4th Jan 20247:00 amRNSDirector/PDMR Shareholding
15th Dec 20235:36 pmRNSDividend Declaration
8th Dec 20231:53 pmRNSDirector/PDMR Shareholding
8th Dec 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
14th Nov 20232:07 pmRNSDoc re. GE Files 8-K
14th Nov 20231:48 pmRNSDoc re. GE Files 8-K
24th Oct 20234:23 pmRNSDoc re. GE Files 8-K
24th Oct 20234:16 pmRNS3rd Quarter Results
4th Oct 20237:00 amRNSDirector/PDMR Shareholding
8th Sep 20235:42 pmRNSDividend Declaration
7th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSDirector/PDMR Shareholding
25th Jul 20232:08 pmRNSDoc re. GE Files 8-K
25th Jul 20232:05 pmRNSDoc re. GE Files 8-K
25th Jul 20232:01 pmRNSDoc re. GE Files 10-Q
6th Jul 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20235:04 pmRNSDividend Declaration
26th Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSDirector/PDMR Shareholding
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSDoc re. GE files Form SD
26th May 20237:00 amRNSDoc re. GE Files Form S-8 Registration Statement
25th May 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.